Article: Applied Biosystems Transfers Its Interest in Celera Diagnostics to Celera Genomics in Exchange for Various Considerations and Cash.

FOSTER CITY, Calif. -- Applied Biosystems Group (NYSE:ABI):

E[acute accent]--Applied Biosystems to Serve End-User Clinical Diagnostics Instrumentation Market as well as Research Markets

E[acute accent]--Conference Call at 10 a.m. EST Tomorrow

E[acute accent]Applera Corporation today announced that its Board of Directors has approved a restructuring of its Celera Diagnostics joint venture, whereby, effective January 1, 2006, Applied Biosystems has transferred its 50 percent interest in the joint venture to Celera Genomics in exchange for a package of considerations to Applied Biosystems. Since its formation in 2001, Celera Diagnostics has been ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!